Sterigenics Completes $17.5 Million Expansion to its Gamma Sterilization Capacity

Sterigenics International LLC, a global provider of contract sterilization, lab services, gamma technologies, and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, has completed a $17.5 million expansion to its Fort Worth, Texas facility, making it the largest sterilization facility in the company’s global network.
 
The latest expansion project includes the installation of a new, state-of-the art Nordion JS10000 gamma irradiator that will dramatically increase Sterigenics’ total capacity, allowing customers to better address their geographic needs by taking advantage of Fort Worth’s status as a commercial gateway to the United States.
 
“Fort Worth’s location along major transportation links makes it a natural distribution and logistics hub for manufacturers and for imports into the United States,” said Philip Macnabb, president of Sterigenics. “Our investment gives Sterigenics the extra capacity we need to benefit from these opportunities and will help make us the provider of choice for sterilization services in the Southwest.”
 
Opened in 1984, Sterigenics’ Fort Worth facility provides routine gamma, GammaStat rapid processing and process validation, and offers laboratory testing services through its Nelson Labs business. The expansion increases the facility’s total sterilization throughput by 60 percent, adding 50,000 pallets per year in capacity, 20 new employees, and 60,000 square feet to the building’s footprint. At 145,000 square feet, Fort Worth is now the largest operation in Sterigenics’ global network.
 
“Local and regional demand for sterilization in Fort Worth has been growing for years,” said Aaron Morrison, general manager. “This additional gamma capacity can shorten turnaround times for sterilization customers, helping them get their products into the market faster.”
 
To address the growing need for sterilization in many parts of the world, Sterigenics is making significant investments in technology to expand both gamma and ethylene oxide (EO) capacity throughout its global network. On the gamma side, in June, 2017, Sterigenics completed a project that tripled throughput at its operation in West Memphis, Ark., and opened a significant expansion in Gurnee, Ill., in 2015. In addition, Sterigenics has expansion projects underway at its EO facilities in Ontario, Canada; Costa Rica, and Wiesbaden, Germany. 
 
Sterigenics International LLC, along with its affiliates, provides outsourced contract sterilization services, laboratory services, gamma technologies and medical isotopes, and claims to be the only vertically integrated sterilization company in the world. Operating out of 43 facilities in 13 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high-performance materials industries. Its affiliate Nordion positions Sterigenics as the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Through Nelson Labs, Sterigenics offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and pharmaceuticals and biologics fields. Sterigenics International LLC and its affiliates serve more than 2,500 customers around the world and is owned by private equity firms Warburg Pincus and GTCR.